Splenectomy and preoperative risks in ABO-incompatible kidney transplants [4]

Transplantation

Volumn 82, Issue 5, 2006, Pages 719-720

  Mitsuhata, Naoki ^a   Fujita, Ryuji ^a   Ito, Seiichi ^a   Mannami, Makoto ^b   Mannami, Rensuke ^b   Kojima, Keimei ^b   Nishi, Mitsuo ^c  

^a Kure Kyosai Hospital   (Japan)

^b Uwajima Tokushukai Hospital   (Japan)

^c KAGAWA ROSAI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIBODY; HLA ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB;

BLOOD GROUP ABO INCOMPATIBILITY; COMPARATIVE STUDY; HIGH RISK PATIENT; HLA SYSTEM; KIDNEY GRAFT; LETTER; PLASMAPHERESIS; PRIORITY JOURNAL; PROPHYLAXIS; SPLENECTOMY; SURGICAL RISK;

ABO BLOOD-GROUP SYSTEM; ANIMALS; BLOOD GROUP INCOMPATIBILITY; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; RETROSPECTIVE STUDIES; RISK FACTORS; SPLENECTOMY;

EID: 33748707980     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000229425.96593.e2     Document Type: Letter

References (4)

1. Gloor JM, Lager DJ, Fidler ME, et al. A comparison of splenectomy vesus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantation. Transplantation 2005; 80: 1572-1577.
2. Mannami M, Mitsuhata N. Improved outcomes after ABO-incompatible living-donor kidney transplantation after 4 weeks of treatment with mycophenolate-mofetil. Transplantation 2005; 79: 1756-1758.
3. 2 without splenectomy appropriate for ABO-incompatible renal transplant? Am J Transplant 2005; 5: 3019.
4. Rodriguez PC, Arroyave IH, Mejia G, et al. Detection of all antibodies against non-HLA antigens in kidney transplantation by flow cytometry. Clinical Transplant 2000; 14: 472-478.